Andreas Fouras
- Home
- Andreas Fouras
Public
Opening a new frontier in treating Parkinson’s disease
- Review
- November 11, 2022
Is this the most hated company on the ASX?
- Review
- August 16, 2019
Latest Articles
Another US win for 4D Medical with FDA approval for CT lung ventilation analysis product
The US Food and Drug Administration (FDA) has given the green light to respiratory imaging technology company 4DMedical (ASX: 4DX) for its CT-based lung ventilation analysis product (CT LVAS™). This FDA clearance will allow 4DMedical to leverage the US’s available CT hardware and boost its presence in the region. The FDA clearance follows the rollout
Read MorePublic
4DMedical’s tech platform now unambiguously in early commercialisation
Back in the 1970s the world marvelled as the then revolutionary CT scan and nuclear medicine technologies that allowed health care professionals to gain never-before-seen insights into patients’ diseased lungs. The 3D pictures they provided were high resolution images that were a vast improvement on the 2D (x-rays) and 1D (spirometry) tests previously available. Fast
Read MorePublic
4DMedical gains momentum as commercialisation gets underway
Unfortunately, COVID seems to be here to stay, with re-infections becoming the new norm, and people dropping like flies. (I, of course, being of superior birth, am yet to contract the spicy flu, but time will tell.) The pandemic saw growth in a few industries like eCommerce, however an interesting subset of pandemic profiteers emerged,
Read MorePublic
4DMedical to compete with fairy bread for best Aussie invention
Australians are a smart bunch. Although the pavlova is disputed, we gladly claim awesome inventions like the black box flight recorder, spray-on skin, the cochlear implant, plastic money and fairy bread (arguably the greatest invention of them all). Whilst I’m not sure much could compete with fairy bread, 4DMedical (ASX: 4DX) are giving it a
Read MorePublic
Move over x-ray: 4D Medical’s respiratory scanning tech could be the new standard in imaging
Invented in 1895 and becoming the standard in the early 1900s, the x-ray has long been the backbone of many medical diagnoses. The relatively unchanged technology has been commonplace for decades, but medtech company 4D Medical (ASX: 4DX) is rethinking the way we diagnose respiratory issues with their proprietary XV Technology™ and Permetium preclinical scanner.
Read MorePublic
4D Medical commences trading on the ASX, opens at 2x IPO Price
Investors that missed out on the IPO for medtech company 4D Medical (ASX: 4DX) have had no qualms buying the stock on market with shares in 4DX opening at $1.47 when trading commenced this morning, more than double the IPO Offer Price of $0.73. The significant jump follows a similar trend among Australian investors that
Read MorePublic
